Treatment of fabry disease with migalastat-outcome from a prospective 24 months observational multicenter study (FAMOUS) Lenders M, Nordbeck P, Kurschat C, Eveslage M, Karabul N, Kaufeld J, Hennermann JB, Patten M, Cybulla M, Müntze J, Üçeyler N, Liu D, Das AM, Sommer C, Pogoda C, Reiermann S, Duning T, Gaedeke J, von Cossel K, Blaschke D, Brand SM, Alexander Mann W, Kampmann C, Muschol N, Canaan-Kühl S, Brand E (2022) In: European Heart Journal - Cardiovascular Pharmacotherapy, 8 Type of Publication: Research article (journal)
Precision medicine in Fabry disease Lenders M, Brand E (2021) In: Nephrology, Dialysis and Transplantation, 36 Type of Publication: Research article (journal)
Generation and Characterization of a Polyclonal Human Reference Antibody to Measure Anti-Drug Antibody Titers in Patients with Fabry Disease Lenders M, Scharnetzki D, Heidari A, Di Iorio D, Wegner SV, Brand E (2021) In: International Journal of Molecular Sciences, 22 Type of Publication: Research article (journal)
Fabry Disease: The Current Treatment Landscape Lenders M, Brand E (2021) In: Drugs, 81 Type of Publication: Research article (journal)
Neutralising anti-drug antibodies in Fabry disease can inhibit endothelial enzyme uptake and activity Stappers F, Scharnetzki D, Schmitz B, Manikowski D, Brand SM, Grobe K, Lenders M, Brand E (2020) In: J Inherit Metab Dis, 2020 Type of Publication: Research article (journal)

Zielgerichtete endogene Genaktivierung der α-Galaktosidase A als möglicher Therapieansatz bei Morbus Fabry Duration: 01/01/2018 - 30/04/2019 Type of project: Own resources project
Observational approach (pilot project): “Lift Yourself” program – safe physical exercise in Fabry Disease (Fabry and Sport) Duration: 01/08/2014 - 31/03/2016 Type of project: Own resources project
Mechanismen der Endothelzell- und Gefäßsteifigkeit in Abhängigkeit vom genetischen Status Duration: 01/06/2011 - 31/05/2014 Funded by: Else Kröner-Fresenius-Foundation Type of project: Individual project